IperionX Ltd (ASX:IPX) saw its shares plummet 7.01% during Wednesday's trading session, as investors reacted to heightened scrutiny of the company's valuation and financial health.

The decline follows news that the titanium producer has shifted its Virginia facility to continuous 24/7 production, transitioning from commissioning to commercial operations. However, analysis indicates shares are trading roughly 31.1% above estimated fair value, signaling potential overvaluation to market participants.

Further financial examination reveals IperionX operates with less than one year of cash runway and has yet to generate meaningful revenue, reporting a net loss of US$34.77 million for the recent half-year period. The stock movement also coincides with the company's posting of a corporate investor presentation on its website, which may have prompted a reassessment of its near-term prospects and capital needs.